Mood Disorders: Clinical Trials

51 trials for Mood Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

20 completed, 13 unknown, 7 recruiting, 4 terminated. 51 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 151Completed 20, Unknown 13, Recruiting 7, Terminated 4, Withdrawn 3, Active not recruiting 2, Enrolling by invitation 1, Not yet recruiting 1

Follow Mood Disorders: new trials by email Literature Review of Mood Disorders trials Research Report on Mood Disorders

Trials (filtered) newest first · largest first

All 51 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Web-based Intervention Program for Postpartum Depression
Web-based program for postpartum depression - Postpartum Depression (PPD), Web-based Intervention
Early Phase 1RecruitingBabes-Bolyai University302026-10-272026-10-28
Single Day of Ultra-accelerated TMS With a Single Dose of NRX-101
TMS, NRX-101 - Major Depression
Early Phase 1RecruitingMclean Hospital302026-10-012026-10-30
Individualized fMRI-guided TMS for Depression
Active Repetitive Transcranial Magnetic Stimulation (rTMS), Sham Transcranial Magnetic Stimulation (TMS) - Depression, Major Depressive Disorder (MDD)
Early Phase 1Not yet recruitingUniversity of Pennsylvania602026-09-152026-09-09
Pilot Study: Establishing Glutamatergic Changes in Rapid Antidepressant Effects of Ketamine
Ketamine only - Major Depressive Disorder (MDD)
Early Phase 1RecruitingUniversity of Pennsylvania102026-04-012026-10-07
Synaptic Mechanisms of Continuous Theta Burst Stimulation in Depression
D-Cycloserine (DCS), Continuous theta-burst stimulation (cTBS), Transcranial Magnetic Stimulation Sham - Major Depression
Early Phase 1RecruitingMclean Hospital802026-03-112026-05-13
Mood Effects of Serotonin Agonists: Depression
LSD, Placebo - LSD, Major Depressive Disorder
Early Phase 1CompletedUniversity of Chicago412025-06-092026-07-10
Feasibility Pilot of Accelerated Stimulation With TMS for Treatment of Major Depressive Disorder (FAST-MDD)
aTMS utilizing the MagVenture TMS device - Major Depressive Disorder
Early Phase 1CompletedUniversity of Minnesota112025-06-092026-02-09
Probiotic Administration for Adolescent Depression
Visbiome, Placebo - Depression
Early Phase 1RecruitingUniversity of California, San Francisco772025-05-152026-07-14
Long-term Potentiation Disruption Underlying Cognitive Impairment in ECT
Electroconvulsive Therapy - Major Depressive Disorder, Bipolar Disorder II
Early Phase 1WithdrawnUniversity of New Mexico2025-01-212026-01-21
Personalized DBS Targeting for Treating Depression
Deep Brain Stimulation(DBS), Esketamine - Treatment-resistant Depression (TRD)
Early Phase 1RecruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine52025-01-052026-04-27
Psychoneuromentalism Disorder: A Medical Condition That Affects People With Psychological Impairments From Health Issues
Decompartmentalization Framework, Liquid Herbal TInctures, Mental Imagery - Schizoaffective Disorder, Bipolar Type, Bipolar Disorder
Early Phase 1UnknownThe Essence of Integrative Health and Medicine Practice302024-10-102024-08-12
Testing a Transdiagnostic TMS Treatment Target
transcranial magnetic stimulation - Major Depressive Disorder, Depression
Early Phase 1CompletedBrigham and Women's Hospital102024-09-092026-07-13
Quetiapine Versus Trazadone in Women With Postpartum Depression
Trazodone, Quetiapine - Postpartum Depression
Early Phase 1UnknownLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's502024-09-012024-08-09
Electroconvulsive Therapy and Concomitant Lithium in Depressive Disorder: A Pilot Study
Lithium - Depressive Disorder
Early Phase 1UnknownMelbourne Health202023-06-012023-08-01
Glutamatergic Adaptation to Stress as a Mechanism for Anhedonia and Treatment Response With Ketamine
Ketamine, Placebo - Major Depressive Disorder
Early Phase 1RecruitingEmory University1402022-11-082026-05-26
A Clinical Study on the Effects of Inhalation of Volatile Oil of Cang-Ai Via the Nose on Patients With Depression
Volatile Oil of Cang-Ai, Bergamot essential oils - Depressive Disorder, Mental Disorder in Adolescence
Early Phase 1UnknownJieqiong Cui602022-11-012022-10-20
Ketamine Therapy Experiential Education Study
Ketamine hydrochloride injection - Psychedelic Experiences, Therapeutic Alliance
Early Phase 1UnknownIntegrative Psychiatry Institute5002022-09-012022-07-21
Effects of Ciprofol Anesthesia on Learning and Memory Function and Antidepressant Effects of ECT in Depressive Patients
ciprofol, Propofol - Depressive Disorder
Early Phase 1UnknownFirst Affiliated Hospital of Chongqing Medical University3902022-03-012022-03-04
Pulse Width 0.15ms vs 0.30ms in Electroconvulsive Therapy
Electroconvulsive therapy - Major Depressive Disorder, Bipolar Depression
Early Phase 1UnknownCharles University, Czech Republic402022-01-182022-07-20
Glutamate and Opioid Mechanisms of Antidepressant Response to Ketamine
Naltrexone, Placebo, Ketamine - Depressive Disorder, Treatment-Resistant
Early Phase 1CompletedKing's College London272021-09-272023-03-02

Showing 20 of 51. Sign in to see all of them.

Narrower conditions

Depressive Disorder, Major (28)  ·  Bipolar Disorder (12)  ·  Depression (12)  ·  Depressive Disorder (7)  ·  Depression, Postpartum (5)  ·  Depressive Disorder, Treatment-Resistant (5)  ·  Anxiety Disorders (3)  ·  Disease (2)  ·  Psychotic Disorders (2)  ·  Schizophrenia (2)  ·  Suicidal Ideation (2)  ·  Attention Deficit Disorder with Hyperactivity (1)  ·  Breast Feeding (1)  ·  Cognitive Dysfunction (1)

Broader conditions

Mental Disorders (50)  ·  Depressive Disorder (35)  ·  Behavior (15)  ·  Behavioral Symptoms (13)  ·  Bipolar and Related Disorders (12)  ·  Female Urogenital Diseases and Pregnancy Complications (5)  ·  Pregnancy Complications (5)  ·  Puerperal Disorders (5)  ·  Urogenital Diseases (5)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (3)  ·  Neurocognitive Disorders (2)  ·  Self-Injurious Behavior (2)

Interventions

Ketamine (8)  ·  Transcranial Magnetic Stimulation (4)  ·  Citalopram (3)  ·  Cycloserine (3)  ·  Acetylcysteine (2)  ·  Deep Brain Stimulation (2)  ·  Docosahexaenoic Acids (2)  ·  Eicosapentaenoic Acid (2)  ·  Escitalopram (2)  ·  (2-(1R)-1-cyclopropyl)ethyl-6-isopropyl-phenol (1)  ·  Aripiprazole (1)  ·  Baclofen (1)  ·  Breathing Exercises (1)  ·  Bupropion (1)  ·  Cannabidiol (1)

Sponsors

Mclean Hospital (3)  ·  Centre for Addiction and Mental Health (2)  ·  University of California, Los Angeles (2)  ·  University of Pennsylvania (2)  ·  William Coryell (2)  ·  Babes-Bolyai University (1)  ·  Beijing Pins Medical Co., Ltd (1)  ·  Brigham and Women's Hospital (1)  ·  Charles University, Czech Republic (1)  ·  China Academy of Chinese Medical Sciences (1)  ·  Emory University (1)  ·  First Affiliated Hospital of Chongqing Medical University (1)  ·  Integrative Psychiatry Institute (1)  ·  Janssen Pharmaceutica N.V., Belgium (1)  ·  Jieqiong Cui (1)

Countries

United States (24)  ·  Canada (6)  ·  China (5)  ·  Australia (1)  ·  Belgium (1)  ·  Czechia (1)  ·  Romania (1)  ·  Sweden (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Jeffrey H Meyer, MD, PhD (2)  ·  A Elias (1)  ·  Andrew Nierenberg, MD (1)  ·  Balwinder Singh, MD, MS (1)  ·  Ben Palanca, MD (1)  ·  Cherry Leung, PhD, RN (1)  ·  Chunshui Yu, MD (1)  ·  Deborah L. Levy, Ph.D. (1)  ·  Douglas Kondo, MD (1)  ·  Eliza Park, MD (1)  ·  Faith A Richardson, BSW, MPA, PhD (1)  ·  Francesca Beaudoin, MD PhD (1)  ·  Gary Hasey, MD (1)  ·  Hanna Molla (1)

Results publications

PMID 15474895, PMID 16677714, PMID 26364274, PMID 26619358, PMID 27869829, PMID 27918562, PMID 28521048, PMID 28551715, PMID 29632383, PMID 29912955, PMID 30423462, PMID 30819549, PMID 31279534, PMID 33309459, PMID 33933839, PMID 34608328, PMID 34711062, PMID 34973601, PMID 35086123, PMID 35738038, PMID 36999619, PMID 37730990, PMID 37815563, PMID 38265467, PMID 38701878, PMID 40224600, PMID 40707608

NIH funding

P20GM109089 (1), R01DA002812 (1), R01DA043535 (1), R01MH059668 (1), R01MH126083 (1), R01MH139697 (1), R33MH135428 (1), R61AT012028 (1)